Reuters logo
BRIEF-Ardelyx to present findings from phase 2b trial of Tenapanor
October 19, 2016 / 12:23 PM / in a year

BRIEF-Ardelyx to present findings from phase 2b trial of Tenapanor

Oct 19 (Reuters) - Ardelyx Inc :

* Ardelyx announces the presentation of positive global endpoint findings from phase 2b trial of Tenapanor in patients with IBS-C at ACG annual meeting

* Ardelyx Inc- also evaluating tenapanor in phase 3 study for treatment of hyperphosphatemia in end-stage renal disease (esrd) patients on dialysis

* Ardelyx Inc- data from phase 3 study for treatment of hyperphosphatemia in ESRD expected to be reported in Q1 of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below